Indaptus Therapeutics Activates Emory Winship Cancer Institute as Trial Site in…
<!-- Name:DistributionId Value:8786583 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Decoy20
Indaptus Therapeutics Announces FDA Clearance of Investigational New Drug Application…
NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announced that the U.S. Food and Drug Administration (FDA) has…